The Pleiotropic Ubiquitin-Specific Peptidase 16 and Its Many Substrates

被引:4
|
作者
Zheng, Jiahuan [1 ,2 ]
Chen, Chunxu [3 ]
Guo, Chunqing [4 ]
Caba, Cody [5 ]
Tong, Yufeng [5 ]
Wang, Hengbin [1 ]
机构
[1] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Dept Internal Med,Div Hematol Oncol & Palliat Care, Richmond, VA 23298 USA
[2] Univ Hong Kong, Li Ka Shing Fac Med, Dept Obstet & Gynecol, Hong Kong 999077, Peoples R China
[3] Virginia Commonwealth Univ, Sch Engn, Dept Bioengn, Richmond, VA 23298 USA
[4] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA 23298 USA
[5] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
ubiquitin-specific peptidase 16; histone H2A; substrates; structure; human diseases; STEM-CELLS; CHOLESTEROL; KINASE; PLK1; PRC1;
D O I
10.3390/cells12060886
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ubiquitin-specific peptidase 16 (USP16) is a deubiquitinase that plays a role in the regulation of gene expression, cell cycle progression, and various other functions. It was originally identified as the major deubiquitinase for histone H2A and has since been found to deubiquitinate a range of other substrates, including proteins from both the cytoplasm and nucleus. USP16 is phosphorylated when cells enter mitosis and dephosphorylated during the metaphase/anaphase transition. While much of USP16 is localized in the cytoplasm, separating the enzyme from its substrates is considered an important regulatory mechanism. Some of the functions that USP16 has been linked to include DNA damage repair, immune disease, tumorigenesis, protein synthesis, coronary artery health, and male infertility. The strong connection to immune response and the fact that multiple oncogene products are substrates of USP16 suggests that USP16 may be a potential therapeutic target for the treatment of certain human diseases.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Vialinin A is a ubiquitin-specific peptidase inhibitor
    Okada, Kiyoshi
    Ye, Yue Qi
    Taniguchi, Kayoko
    Yoshida, Ayaka
    Akiyama, Tomonori
    Yoshioka, Yasukiyo
    Onose, Jun-ichi
    Koshino, Hiroyuki
    Takahashi, Shunya
    Yajima, Arata
    Abe, Naoki
    Yajima, Shunsuke
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (15) : 4328 - 4331
  • [2] Ubiquitin-specific peptidase 22 functions and its involvement in disease
    Melo-Cardenas, Johanna
    Zhang, Yusi
    Zhang, Donna D.
    Fang, Deyu
    ONCOTARGET, 2016, 7 (28) : 44848 - 44856
  • [3] Ubiquitin-specific peptidase 22 in cancer
    Feng, Tingting
    Ling, Sunbin
    Xu, Chenyang
    Ying, Lisha
    Su, Dan
    Xu, Xiao
    CANCER LETTERS, 2021, 514 : 30 - 37
  • [4] Ubiquitin-specific peptidase 1: assessing its role in cancer therapy
    Huang, Peng
    Wang, YuHan
    Zhang, PengFei
    Li, Qiu
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 2953 - 2966
  • [5] Ubiquitin-specific peptidase 1: assessing its role in cancer therapy
    Peng Huang
    YuHan Wang
    PengFei Zhang
    Qiu Li
    Clinical and Experimental Medicine, 2023, 23 : 2953 - 2966
  • [6] Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors
    Chen, Shiyao
    Liu, Yunqi
    Zhou, Huchen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [7] The expression of ubiquitin-specific peptidase 8 and its prognostic role in patients with breast cancer
    Qiu, Han
    Kong, Jun
    Cheng, Yunfei
    Li, Gang
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (12) : 10051 - 10058
  • [8] Role of Ubiquitin-Specific Peptidase 47 in Cancers and Other Diseases
    Pan, Kailing
    Fu, Junhao
    Xu, Wenxia
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [9] Ubiquitin-specific peptidase 18 regulates the differentiation and function of Treg cells
    Yang, Lu
    Jing, Yukai
    Kang, Danqing
    Jiang, Panpan
    Li, Na
    Zhou, Xinrong
    Chen, Yan
    Westerberg, Lisa S.
    Liu, Chaohong
    GENES & DISEASES, 2021, 8 (03) : 344 - 352
  • [10] Behavioral Characteristics of Ubiquitin-Specific Peptidase 46-Deficient Mice
    Imai, Saki
    Kano, Makoto
    Nonoyama, Keiko
    Ebihara, Shizufumi
    PLOS ONE, 2013, 8 (03):